(Q33334720)

English

Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

G Krajnik

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Mohn-Staudner

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J Thaler

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

R Greil

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Schmeikal

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

F Marhold

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J Deutsch

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Preiss

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

R Malayeri

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

C Schäfer-Prokop

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

W Wein

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H Huber

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

R Pirker

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

993-998

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008370704612

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008370704612

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33334720&oldid=1523779828"